Abstract:Abstract The autoimmune disorder systemic lupus erythematosus is thought to be caused by the inefficient clearance of dying cells. This releases nucleic acid debris that stimulates type I interferon (T1 IFN) secretion. Plasmacytoid dendritic cells (pDCs) are the major source of T1 IFNs, which are causally linked to lupus pathogenesis. Both T1 IFNs and pDCs are thus the focus of intense studies for immunotherapies. The serine-threonine kinase, tumor progression locus 2 (TPL2), negatively regulates T1 IFN secretion by conventional dendritic cells (cDCs) and macrophages in response to Toll-like receptor 9 (TLR9) stimulation in vitro. In contrast, we and others have shown that TPL2 is required for T1 IFN production in TLR9-stimulated pDCs. The goal of this study is to validate TPL2-dependent regulation of pDC function in vivoand to delineate the mechanisms responsible. Both cDCs and pDCs develop normally in Tpl2−/−mice, but Tpl2−/−mice show defective secretion of T1 IFNs and proinflammatory cytokines in response to administration of CpG (TLR9) or R848 (TLR7) in vivo. The same defect in T1 IFN and proinflammatory cytokine production was observed in bone marrow-derived pDCs and cDCs in vitro. A modest defect in TLR-induced expression of maturation markers CD80, CD86 and MHC class II was seen in Tpl2−/−pDCs, suggesting impaired NFkB activation. Flow cytometric measurement of phosphoproteins demonstrated that TPL2 is also required for TLR-induced activation of MAPK and ribosomal S6 kinase pathways in pDCs. Ongoing studies are examining the role of TPL2 in TLR trafficking and lupus pathogenesis. These data establish TPL2-dependent regulation of pDC functions, which may be exploited for therapeutic intervention in lupus or other IFN-related diseases. Supported by grants from NIH/NIAMS (R21 AR075317) titled "Tpl2 regulation of pDC function and SLE pathogenesis"

TPL2 Mediates Autoimmune Inflammation Through Activation of the TAK1 Axis of IL-17 Signaling

Rkip Mediates Autoimmune Inflammation By Positively Regulating Il-17r Signaling

Function of CK2 kinase activity in Th17 cell polarization and EAE (BA4P.125)

Phosphatase PP2A is Essential for T H 17 Differentiation

TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

MINK1 Kinase Suppresses TH17 Differentiation and Autoimmune Inflammation Via Inhibition of the TGF-β Pathway

Phosphatase PP2A is essential for TH17 differentiation.

Engagement of Toll-like Receptor 2 Enhances Interleukin (IL)-17(+) Autoreactive T Cell Responses Via P38 Mitogen-Activated Protein Kinase Signalling in Dendritic Cells.

The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation

An Autonomous Activation of Interleukin-17 Receptor Signaling Sustains Inflammation and Promotes Disease Progression.

Control of IL-17 Receptor Signaling and Tissue Inflammation by the P38α–mkp-1 Signaling Axis in a Mouse Model of Multiple Sclerosis

Tumor Progression Locus 2 Promotes Mouse Plasmacytoid Dendritic Cell Cytokine Secretion and Signaling

Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation

The novel small-molecule TPN10456 inhibits Th17 cell differentiation and protects against experimental autoimmune encephalomyelitis.

Tumor Progression Locus 2 (tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration During Acute Inflammation

Mir-17-92 Cluster Targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to Promote TH17-mediated Inflammation.

Role of Smad and Non-Smad Signals in the Development of Th17 and Regulatory T Cells (49.3)

Transforming growth factor (TGF)-β-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit α (PKACα) and X-linked protein kinase (PRKX)

TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice

Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis

T Cell-Intrinsic ASC Critically Promotes Th17-mediated Experimental Autoimmune Encephalomyelitis.